Bernard J. Zovighian - 11 May 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: CEO, Director
Issuer ticker: EW
Reported as of: 11 May 2026
Net transaction value: -$2,833,013
SEC form: 4
Accepted by SEC: 12 May 2026, 16:55:45 UTC
Prior SEC filing: 11 May 2026
Next SEC filing: 17 Jun 2026
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Key filing fact

Bernard J. Zovighian filed Form 4 for Edwards Lifesciences Corp (EW) on 12 May 2026.

Key facts

This page summarizes Bernard J. Zovighian's Form 4 filing for Edwards Lifesciences Corp (EW).
7 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 May 2026, 16:55.

Change

Previous filing in this sequence was filed on 11 May 2026.
Current net transaction value: -$2,833,013.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001665141 Primary reporting owner

Zovighian Bernard J

Relationship: CEO, Director
Address: ONE EDWARDS WAY, IRVINE
Signature: Linda J. Park, Attorney-in-Fact
Signature date: 12 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Options Exercise

Transaction value
Shares: +47,207
Change %: +43%
Price: $0.000000^*
Shares after: 157,492
Date: 11 May 2026
Ownership: Direct
Footnotes: F1

EW transaction

Common Stock

Tax liability

Transaction value
Shares: -26,198
Change %: -17%
Price: $79.96^*
Shares after: 125,805
Date: 11 May 2026
Ownership: Direct

EW transaction

Common Stock

Gift

Transaction value
Shares: -26,640
Change %: -21%
Price: $0.000000^*
Shares after: 99,165
Date: 12 May 2026
Ownership: Direct

EW transaction

Common Stock

Gift

Transaction value
Shares: +26,640
Change %: +122%
Price: $0.000000^*
Shares after: 48,391
Date: 12 May 2026
Ownership: By Trust

EW transaction

Common Stock

Sale

Transaction value: $66,250
Shares: -845
Change %: -1.7%
Price: $78.40
Shares after: 47,546
Date: 12 May 2026
Ownership: By Trust
Footnotes: F2, F3

EW transaction

Common Stock

Sale

Transaction value: $2,766,762
Shares: -35,506
Change %: -75%
Price: $77.92
Shares after: 12,040
Date: 12 May 2026
Ownership: By Trust
Footnotes: F2, F4

EW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,734
Date: 11 May 2026
Ownership: 401(k)

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EW transaction Derivative

Performance Rights

Options Exercise

Transaction value
Shares: -47,207
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 47,207
Exercise price
Footnotes: F1, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4.

Footnote F2

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $78.390 to $78.430. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Footnote F4

This transaction was executed in multiple trades at prices ranging from $77.375 to $78.360. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Footnote F5

These Performance Rights expire on May 10, 2030.

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.